124 related articles for article (PubMed ID: 33341703)
1. Analysis of 24 cases of epithelioid glioblastoma: Experience from a tertiary centre of North India.
Chatterjee D; Radotra BD; Aggarwal D; Madan R; Gupta SK
Ann Diagn Pathol; 2021 Feb; 50():151679. PubMed ID: 33341703
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma.
Wang J; Liu Z; Cui Y; Liu Y; Fang J; Xu L; He Y; Du J; Su Y; Zou W; Xu Z; Li G
J Neurooncol; 2019 Aug; 144(1):137-146. PubMed ID: 31214915
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis.
Rekhi B; Kosemehmetoglu K; Tezel GG; Dervisoglu S
APMIS; 2017 Aug; 125(8):679-689. PubMed ID: 28452074
[TBL] [Abstract][Full Text] [Related]
4. [Epithelioid glioblastoma with BRAF V600E mutation: a clinicopathological and molecular study].
Zheng LM; Gong J; Zou Y; Zhang MN; Yu TP; Hou J; Zhou Q; Chen N
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):229-235. PubMed ID: 33677887
[No Abstract] [Full Text] [Related]
5. BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.
Kleinschmidt-DeMasters BK; Aisner DL; Foreman NK
Am J Surg Pathol; 2015 Apr; 39(4):528-40. PubMed ID: 25581727
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and molecular genetic study on epithelioid glioblastoma: Series of seven cases with review of literature.
Khanna G; Pathak P; Suri V; Sharma MC; Chaturvedi S; Ahuja A; Bhardwaj M; Garg A; Sarkar C; Sharma R
Pathol Res Pract; 2018 May; 214(5):679-685. PubMed ID: 29615337
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations.
Murakami C; Yoshida Y; Yamazaki T; Yamazaki A; Nakata S; Hokama Y; Ishiuchi S; Akimoto J; Shishido-Hara Y; Yoshimoto Y; Matsumura N; Nobusawa S; Ikota H; Yokoo H
Brain Tumor Pathol; 2019 Jul; 36(3):103-111. PubMed ID: 30972500
[TBL] [Abstract][Full Text] [Related]
10. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H
Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198
[TBL] [Abstract][Full Text] [Related]
11. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
Sugimoto K; Ideguchi M; Kimura T; Kajiwara K; Imoto H; Sadahiro H; Ishii A; Kawano H; Ikeda E; Suzuki M
Brain Tumor Pathol; 2016 Apr; 33(2):137-46. PubMed ID: 26667174
[TBL] [Abstract][Full Text] [Related]
13. A rare case of BRAF V600E-mutated epithelioid glioblastoma with a sarcomatous component.
Ishikawa R; Kadota K; Hayashi T; Kimura N; Inoue K; Ibuki E; Kagawa S; Kushida Y; Okada M; Miyake K; Tamiya T; Nobusawa S; Hirato J; Haba R
Pathol Int; 2020 Mar; 70(3):166-170. PubMed ID: 31903645
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics and treatment outcomes of epithelioid glioblastoma.
Sun K; Zhou X; Li T; Zuo M; Li J; Liu Y
Neurosurg Rev; 2021 Dec; 44(6):3335-3348. PubMed ID: 33598819
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and outcomes in embryonal tumor with multilayered rosettes: A decade long experience from a tertiary care centre in North India.
Gupta K; Sood R; Salunke P; Chatterjee D; Madan R; Ahuja CK; Jain R; Trehan A; Radotra BD
Ann Diagn Pathol; 2021 Aug; 53():151745. PubMed ID: 33964610
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation.
Nobusawa S; Hirato J; Kurihara H; Ogawa A; Okura N; Nagaishi M; Ikota H; Yokoo H; Nakazato Y
Brain Pathol; 2014 Apr; 24(3):239-46. PubMed ID: 24354918
[TBL] [Abstract][Full Text] [Related]
17. A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.
Kuroda J; Nobusawa S; Nakamura H; Yokoo H; Ueda R; Makino K; Yano S; Kuratsu J
Neuropathology; 2016 Apr; 36(2):181-6. PubMed ID: 26375727
[TBL] [Abstract][Full Text] [Related]
18. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells.
Koelsche C; Wöhrer A; Jeibmann A; Schittenhelm J; Schindler G; Preusser M; Lasitschka F; von Deimling A; Capper D
Acta Neuropathol; 2013 Jun; 125(6):891-900. PubMed ID: 23435618
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic non-infantile astrocytoma/ganglioglioma: rare low-grade tumor with frequent BRAF V600E mutation.
Chatterjee D; Garg C; Singla N; Radotra BD
Hum Pathol; 2018 Oct; 80():186-191. PubMed ID: 29902580
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological, Immunohistochemical and Molecular Genetic Study on Epithelioid Glioblastoma: A Series of Fifteen Cases with Literature Review.
Zeng Y; Zhu X; Wang Y; Liu B; Yang X; Wang Q; Du J; Ma Y; Lin L; Fu P; Xiao H; Guo QN
Onco Targets Ther; 2020; 13():3943-3952. PubMed ID: 32440157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
